Lv31
302 积分 2025-10-29 加入
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia
1个月前
已完结
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
1个月前
已完结
Aberrant activation of m6A demethylase FTO renders HIF2α low/− clear cell renal cell carcinoma sensitive to BRD9 inhibitors
1个月前
已完结
New leap of BRD9 inhibitor: Imidazole substituents making BRD9 inhibitors excellent drug candidates for AML
4个月前
已关闭
Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes
5个月前
已完结
Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes
5个月前
已完结
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
6个月前
已完结
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
6个月前
已完结
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9
6个月前
已完结
皖公网安备34019202002308
